-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U2mToXqre0VHARgIgP+v3k/ku7Hlg0K7AZk4/2OaGaBFbBZSF+402uih5PSJv6lN tqZ8FsdowncC4adW3pAgEQ== 0000950117-03-001513.txt : 20030416 0000950117-03-001513.hdr.sgml : 20030416 20030416162409 ACCESSION NUMBER: 0000950117-03-001513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030416 FILED AS OF DATE: 20030416 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 03652797 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: NEEDLEMAN PHILIP CENTRAL INDEX KEY: 0001083221 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 BUSINESS PHONE: 3146941000 MAIL ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 4 1 a34567.txt PHILIP NEEDLEMAN Form 4 Page 1 of 2 ---------------------------- - --------------- OMB APPROVAL FORM 4 ---------------------------- - --------------- OMB Number: 3235-0287 ---------------------------- Expires: January 31, 2005 ---------------------------- Estimated average burden hours per response... 0.5 ---------------------------- [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
- ------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol Needleman, Philip Pharmacia Corporation PHA - ------------------------------------------------------------------------------------------------------------------------ (Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for Number of Reporting Month/Day/Year Person, if an entity 04/16/2003 (voluntary) 100 Route 206 North - ------------------------------------------------------------------------------------------------------------------------ (Street) 5. If Amendment, Date of Original (Month/Day/Year) Peapack, NJ 07977 - ------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip)
- --------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner -------- ------- X Officer (give Other (specify -------- title below) ------- below) Senior Executive Vice President - --------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person - ------ Form filed by More than One Reporting Person - ------ - ---------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------------- Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - -------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Transaction Date 2A. Deemed 3. Transaction 4. Securities Acquired (A) (Instr. 3) (Month/Day/Year) Execution Code or Disposed of (D) Date, (Instr.8) (Instr. 3, 4 and 5) if any --------------------------------------------------------- (Month/ Code V Amount (A) or Price Day/ (D) Year) - -------------------------------------------------------------------------------------------------------------------------- Common 02/04/2003 G V 2,000 D - -------------------------------------------------------------------------------------------------------------------------- Common 04/16/2003 J(1) 196,005 D - -------------------------------------------------------------------------------------------------------------------------- Common 04/16/2003 J(1) 16,107 D - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------ 5. Amount of 6. Ownership 7. Nature of Securities Form: Direct Indirect Beneficially (D) or Indirect (I) Beneficial Owned Following (Instr. 4) Ownership Reported Transaction(s) (Instr. 4) (Instr. 3 and 4) - ------------------------------------------------------------------------------------ D - ------------------------------------------------------------------------------------ 0 D - ------------------------------------------------------------------------------------ 0 I Savings Plans - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------
Form 4 Page 2 of 2 Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - -------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 3A. Deemed Execution 4. Transac- 5. Number of Security (Instr. 3) sion or action Date, if any tion Code Derivative Exercise Date (Month/Day/Year) (Instr. 8) Securities Price of (Month/ Acquired (A) Derivative Day/ or Disposed of Security Year) (D) (Instr. 3, 4 and 5) ----------------------------------- Code V (A) (D) - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $13.41 04/16/2003 J(1) 147,758 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $26.18 04/16/2003 J(1) 263,854 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $31.88 04/16/2003 J(1) 204,315 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $71.06 04/16/2003 J(1) 79,597 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $47.58 04/16/2003 J(1) 81,165 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $48.32 04/16/2003 J(1) 21,728 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $48.88 04/16/2003 J(1) 131,926 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $46.52 04/16/2003 J(1) 131,927 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $39.27 04/16/2003 J(1) 235,056 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $39.27 04/16/2003 J(1) 2,412 - -------------------------------------------------------------------------------------------------------------------- Performance Share Units 1-for-1 04/16/2003 J(1) 108,874 - -------------------------------------------------------------------------------------------------------------------- Performance Share Units 1-for-1 04/16/2003 J(1) 45,977 - --------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------- 6. Date Exercisable 7. Title and Amount of 8. Price of 9. Number of and Expiration Date Underlying Securities Derivative Derivative (Month/Day/Year) (Instr. 3 and 4) Security Securities (Instr. 5) Beneficially Owned Following Reported Transaction(s) (Instr. 4) - ------------------------ --------------------------- Date Expi- Title Amount or Exercis- ration Number of able Date Shares - ------------------------------------------------------------------------------------------- (2) 02/24/2004 Common 147,758 0 - ------------------------------------------------------------------------------------------- (2) 04/25/2006 Common 263,854 0 - ------------------------------------------------------------------------------------------- (2) 02/26/2007 Common 204,315 0 - ------------------------------------------------------------------------------------------- (2) 04/23/2007 Common 79,597 0 - ------------------------------------------------------------------------------------------- (2) 02/25/2008 Common 81,165 0 - ------------------------------------------------------------------------------------------- (2) 06/30/2009 Common 21,728 0 - ------------------------------------------------------------------------------------------- (2) 05/31/2010 Common 131,926 0 - ----------------------------------------------------------------------------------------- (2) 04/02/2011 Common 131,927 0 - ------------------------------------------------------------------------------------------- (2) 01/02/2012 Common 235,056 0 - ------------------------------------------------------------------------------------------- 01/04/2005 01/04/2012 Common 2,412 0 - ------------------------------------------------------------------------------------------- (3) Common 108,874 0 - ------------------------------------------------------------------------------------------- (4) (5) Common 45,977 0 - ------------------------------------------------------------------------------------------- - ------------------------------------ 10. Ownership 11. Nature Form of of Indirect Derivative Beneficial Securities Ownership Beneficially (Instr. 4) Owned at End of Month (Instr. 4) - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - ----------------------------------- D - -----------------------------------
Explanation of Responses: (1) Each share of Pharmacia Common Stock (PHA) held by the reporting person was exchanged for 1.4 shares of Pfizer Common Stock (PFE), pursuant to the Pfizer/Pharmacia merger agreement adopted by the Pfizer and Pharmacia shareholders on December 6 & 9, 2002, respectively. (2) Option is currently exercisable. (3) Target awards provided under the Founders Performance Contingent Shares Program vest at the greater of the target award or the percentage of the target award payable based on the period-to-date performance calculated as of the date of the change in control. The award increases to 125% of the participant's target award if the participant is employed by the company or an affiliate two years after the change in control, or is involuntarily terminated other than for cause within two years after change in control and, if such amount is greater than the calculation above. (4) At the end of each calendar year 2002, 2003 and 2004, 1/3 of the units will be eligible for allocation based on Company performance for that year. (5) Distribution under the plan commences the calendar year following retirement, termination, death or disability, based on the provisions of the Savings+Plus deferred compensation plan. /s/ Don W. Schmitz April 16, 2003 -------------------------------- ----------------- **Signature of Reporting Person Date Don W. Schmitz, attorney-in-fact for Philip Needleman Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the form is filed by more than one reporting person, see Instruction 4(b)(v). **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. -----END PRIVACY-ENHANCED MESSAGE-----